TrialImmunology2008

Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.

Arthur A Vandenbark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.